NATCOPHARM — Natco Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual balance sheet for Natco Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,241	4,061	7,931	13,912	29,173
Net Total Accounts Receivable
Net Total Receivables	5,904	8,380	10,336	14,217	12,560
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,373	24,972	30,003	40,235	52,700
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22,372	23,084	23,034	24,350	26,573
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	47,919	51,091	56,574	69,063	86,308
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,256	7,104	6,831	9,728	9,435
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	6,703	8,455	7,836	10,532	10,238
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	41,216	42,636	48,738	58,531	76,070
Total Liabilities & Shareholders' Equity	47,919	51,091	56,574	69,063	86,308
Total Common Shares Outstanding